Personal information

Other IDs

Scopus Author ID: 35111183600

Countries

Poland

Activities

Collapse all

Employment (1)

Poznan University of Medical Sciences: Poznań, PL

2014-09-24 to present | Research Assistant, Lecturer (Department of Cancer Immunology)
Employment
Source: Self-asserted source
Anna Florczak

Education and qualifications (3)

Poznan University of Medical Sciences: Poznań, PL

2010-10-01 to 2015-01-21 | PhD of Medical Sciences (Department of Cancer Immunology)
Education
Source: Self-asserted source
Anna Florczak

Adam Mickiewicz University in Poznań: Poznań, PL

2010-10-01 to 2014-09-30 | PhD of Medical Sciences (Physics Department, NanoBioMedical Centre)
Education
Source: Self-asserted source
Anna Florczak

University of Life Sciences in Poznań: Poznań, PL

2004-10-01 to 2009-06-29 | Master of Science in Biotechnology
Education
Source: Self-asserted source
Anna Florczak

Works (20)

Physiological and tumor-associated angiogenesis: Key factors and therapy targeting VEGF/VEGFR pathway

Biomedicine & Pharmacotherapy
2024-11 | Journal article
DOI: 10.1016/j.biopha.2024.117585
Contributors: Patryk Lorenc; Agata Sikorska; Sara Molenda; Natalia Guzniczak; Hanna Dams-Kozlowska; Anna Florczak
Source: check_circle
Crossref

Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter

Cancers
2023-11-29 | Journal article
DOI: 10.3390/cancers15235647
Contributors: Sara Molenda; Agata Sikorska; Anna Florczak; Patryk Lorenc; Hanna Dams-Kozlowska
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

SRY-Related Transcription Factors in Head and Neck Squamous Cell Carcinomas: In Silico Based Analysis

Current Issues in Molecular Biology
2023-11-24 | Journal article
DOI: 10.3390/cimb45120592
Contributors: Tomasz Kolenda; Zuzanna Graczyk; Barbara Żarska; Wojciech Łosiewski; Mikołaj Smolibowski; Adrian Wartecki; Joanna Kozłowska-Masłoń; Kacper Guglas; Anna Florczak; Urszula Kazimierczak et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

ZNF643/ZFP69B Exerts Oncogenic Properties and Associates with Cell Adhesion and Immune Processes

International Journal of Molecular Sciences
2023-11-15 | Journal article
DOI: 10.3390/ijms242216380
Contributors: Urszula Oleksiewicz; Marta Machnik; Joanna Sobocińska; Sara Molenda; Anna Olechnowicz; Anna Florczak; Julia Mierzejewska; Dominika Adamczak; Mikołaj Smolibowski; Mariusz Kaczmarek et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

ZNF714 Supports Pro-Oncogenic Features in Lung Cancer Cells

International Journal of Molecular Sciences
2023-10-24 | Journal article
DOI: 10.3390/ijms242115530
Contributors: Urszula Oleksiewicz; Marta Machnik; Joanna Sobocińska; Sara Molenda; Anna Olechnowicz; Anna Florczak; Mikołaj Smolibowski; Mariusz Kaczmarek
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy

Cancers
2021-10-27 | Journal article
DOI: 10.3390/cancers13215389
Contributors: Anna Florczak; Tomasz Deptuch; Kamil Kucharczyk; Hanna Dams-Kozlowska
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Ms1-Type Bioengineered Spider Silk Nanoparticles Do Not Exhibit Toxicity in An In Vivo Mouse Model

Nanomedicine
2021-08 | Journal article
DOI: 10.2217/nnm-2021-0029
Contributors: Tomasz Deptuch; Anna Florczak; Anna Lewandowska; Ewa Leporowska; Karolina Penderecka; Andrzej Marszalek; Andrzej Mackiewicz; Hanna Dams-Kozlowska
Source: check_circle
Crossref

Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells

Journal of Nanobiotechnology
2020-12 | Journal article
DOI: 10.1186/s12951-020-00609-2
Part of ISSN: 1477-3155
Source: Self-asserted source
Anna Florczak

Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo

Journal of Nanobiotechnology
2020-12 | Journal article
DOI: 10.1186/s12951-020-00734-y
Part of ISSN: 1477-3155
Source: Self-asserted source
Anna Florczak

Silk Particles as Carriers of Therapeutic Molecules for Cancer Treatment

Materials
2020-11 | Journal article | Author
DOI: 10.3390/ma13214946
Contributors: Anna Florczak; Inga Grzechowiak; Tomasz Deptuch; Kamil Kucharczyk; Alicja Kaminska; Hanna Dams-Kozlowska
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

<p>Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres</p>

International Journal of Nanomedicine
2019-08 | Journal article
DOI: 10.2147/IJN.S217854
Contributors: Anna Florczak; Andrzej Mackiewicz; Hanna Dams-Kozlowska
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins

Nanomedicine
2018 | Journal article
DOI: 10.2217/nnm-2017-0276
EID:

2-s2.0-85041594549
Contributors: Jastrzebska, K.; Florczak, A.; Kucharczyk, K.; Lin, Y.; Wang, Q.; Mackiewicz, A.; Kaplan, D.L.; Dams-Kozlowska, H.
Source: Self-asserted source
Anna Florczak via Scopus - Elsevier

Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics

Journal of Biomedical Materials Research Part A
2018-12 | Journal article
DOI: 10.1002/jbm.a.36516
Contributors: Anna Florczak; Katarzyna Jastrzebska; Wojciech Bialas; Andrzej Mackiewicz; Hanna Dams‐Kozlowska
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Blending two bioengineered spider silks to develop cancer targeting spheres

Journal of Materials Chemistry B
2017 | Journal article
DOI: 10.1039/c7tb00233e
EID:

2-s2.0-85018484186
Contributors: Florczak, A.; Jastrzebska, K.; Mackiewicz, A.; Dams-Kozlowska, H.
Source: Self-asserted source
Anna Florczak via Scopus - Elsevier

Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment

Acta Biomaterialia
2017 | Journal article
DOI: 10.1016/j.actbio.2017.07.014
EID:

2-s2.0-85023635411
Contributors: Kozlowska, A.K.; Florczak, A.; Smialek, M.; Dondajewska, E.; Mackiewicz, A.; Kortylewski, M.; Dams-Kozlowska, H.
Source: Self-asserted source
Anna Florczak via Scopus - Elsevier

Peptide-functionalized ZCIS QDs as fluorescent nanoprobe for targeted HER2-positive breast cancer cells imaging

Acta Biomaterialia
2016 | Journal article
DOI: 10.1016/j.actbio.2016.02.002
EID:

2-s2.0-84962934162
Contributors: Michalska, M.; Florczak, A.; Dams-Kozlowska, H.; Gapinski, J.; Jurga, S.; Schneider, R.
Source: Self-asserted source
Anna Florczak via Scopus - Elsevier

Silk as an innovative biomaterial for cancer therapy

Reports of Practical Oncology and Radiotherapy
2015 | Journal article
DOI: 10.1016/j.rpor.2014.11.010
EID:

2-s2.0-84924004081
Contributors: Jastrzebska, K.; Kucharczyk, K.; Florczak, A.; Dondajewska, E.; Mackiewicz, A.; Dams-Kozlowska, H.
Source: Self-asserted source
Anna Florczak via Scopus - Elsevier

Functionalized spider silk spheres as drug carriers for targeted cancer therapy

Biomacromolecules
2014 | Journal article
DOI: 10.1021/bm500591p
EID:

2-s2.0-84905816340
Contributors: Florczak, A.; Mackiewicz, A.; Dams-Kozlowska, H.
Source: Self-asserted source
Anna Florczak via Scopus - Elsevier

[Engineered spider silk: the intelligent biomaterial of the future. Part I].,Inżynierowany jedwab pajeczy: inteligentny biomateriał przyszłości. Cześć I.

Postpy higieny i medycyny doświadczalnej (Online)
2011 | Journal article
EID:

2-s2.0-84855468749
Contributors: Florczak, A.; Piekoś, K.; Kaźmierska, K.; Mackiewicz, A.; Dams-Kozłowska, H.
Source: Self-asserted source
Anna Florczak via Scopus - Elsevier

[Engineered spider silk: the intelligent biomaterial of the future. Part II].,Inżynierowany jedwab pajeczy: inteligentny biomateriał przyszłości. Cześć II.

Postpy higieny i medycyny doświadczalnej (Online)
2011 | Journal article
EID:

2-s2.0-84855448057
Contributors: Kaźmierska, K.; Florczak, A.; Piekoś, K.; Mackiewicz, A.; Dams-Kozłowska, H.
Source: Self-asserted source
Anna Florczak via Scopus - Elsevier
How many people are using ORCID?